Erlotinib Completed Phase 1 Trials for Cancer of the Gallbladder / Malignant Neoplasm of Pancreas / Liver Cancer / Periampullary Adenocarcinoma / Extrahepatic Bile Duct Cancer / Small Intestine Cancer Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00987766 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |